Endocrine Carcinoma — Trials

Endocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 574
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +1.5%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (236)

clinicaltrialsPublishedShowing 151–185 of 185 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05120271	BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors(DUET-1)	active not recruiting	Phase 1 / Phase 2	7	Sotio Biotech Inc.INDUSTRY	2	Dec 5, 2025	clinicaltrials
NCT04624477	Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer	active not recruiting	—	450	University Health Network, TorontoOTHER	1	Nov 28, 2025